BioHealth News Archive
Emmes Chosen as a Top Area Workplace
ROCKVILLE, Md., June 17, 2020 /PRNewswire/ -- Emmes today announced that it was selected as one of the best places to work in the greater…
Read More
GSK Expands Synthetic Lethality Scope With $120M Ideaya Bio Alliance – Xconomy
GlaxoSmithKline got its first taste of synthetically lethal cancer therapies via an acquisition. Now it’s trying for a bigger bite of this emerging drug…
Read More
Royalty Pharma, drug firm that doesn’t develop drugs, shatters IPO record
Royalty Pharma, a business built on investing in other people’s medicines, raised $2.2 billion in a record IPO on Tuesday, and the early hours…
Read More
Sirnaomics and Precision NanoSystems Have Formed a Partnership | BioSpace
Developing and Manufacturing Novel RNAi drug Candidates Using Precision NanoSystems' NxGen™ Platform GAITHERSBURG, MD and VANCOUVER, BC, June 17, 2020 /PRNewswire/ - Sirnaomics Inc. (Sirnaomics)…
Read More
Rexahn and Ocuphire Enter into Definitive Merger Agreement :: Rexahn Pharmaceuticals, Inc. (REXN)
ROCKVILLE, Md. and FARMINGTON HILLS, Mich., June 17, 2020 (GLOBE NEWSWIRE) -- Rexahn Pharmaceuticals, Inc. (NasdaqCM: REXN) and Ocuphire Pharma, Inc., a privately-held clinical-stage…
Read More
Emergent Bio to invest $75M in Canton site (NYSE:EBS) | Seeking Alpha
Emergent BioSolutions (NYSE:EBS) will invest $75M in its Canton, Massachusetts facility, focused on the development and manufacturing of drug substance for live viral vaccines…
Read More
Emergent BioSolutions Adding Approximately 300 Jobs After New COVID-19 Vaccine Contracts
Business is booming for Emergent BioSolutions as it has assisted in the country’s push to create COVID-19 treatments and vaccines. Emergent is developing two…
Read More
Emergent BioSolutions Enters Viral Vector And Gene Therapy Arena – Contract Pharma
Emergent BioSolutions has unveiled plans to strengthen its contract development and manufacturing (CDMO) capabilities by expanding into viral vector and gene therapy. The company…
Read More
Lockheed’s ventures arm backs quantum computing and training tech firms — Washington Technology
Lockheed Martin Ventures -- the defense company’s technology startup investment arm -- has backed two companies through separate avenues announced this week. In a…
Read More
Glyscend Therapeutics Completes $20.5M Financing Round to Advance Novel Oral Polymer Therapy for Type 2 Diabetes
BALTIMORE, June 11, 2020 (GLOBE NEWSWIRE) -- Glyscend Therapeutics, a privately held biopharmaceutical company developing novel treatments for type 2 diabetes (T2D) and related…
Read More
BioHealth Capital Region Spotlighted at RESI
The BioHealth Capital Region featured at last week’s Redefining Early Stage Investments Conference (RESI) where speakers from the region discussed a range of topics…
Read More
Creatv Announces Ability to Predict Immunotherapy Treatment Response for Non-Small Cell Lung Cancer (NSCLC) using a Simple Blood Test | Business Wire
ROCKVILLE, Md.--(BUSINESS WIRE)--Creatv Microtech, a privately-held biotechnology company has pioneered a blood test to predict treatment response in patients with stage II-III NSCLC treated…
Read More
Fina Biosolutions Receives SBIR Matching Grant from Montgomery County, MD
Fina Biosolutions recently received a $25,000 Montgomery County SBIR/STTR Phase I matching grant to support its NIH SBIR grant focused on “Genetically detoxified tetanus…
Read More
We shouldn’t care who wins the vaccine ‘race’ – The Washington Post
Regarding the June 4 front-page article “Cold War echoes in race for vaccine,” about the “race” among nations, notably the United States, China, and…
Read More
Producing Enough Vaccine For The Coronavirus Means Companies Have To Start Now : Shots – Health News : NPR
Once upon a time, developing a new vaccine was a step-by-step process that went from concept, to design, to tests in humans, to regulatory…
Read More